The store will not work correctly when cookies are disabled.
4,5-Dihydro-4,6-di-p-tolyl-2H-indazol-3-ol
ID: ALA2272760
PubChem CID: 71570358
Max Phase: Preclinical
Molecular Formula: C21H20N2O
Molecular Weight: 316.40
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccc(C2=Cc3n[nH]c(O)c3C(c3ccc(C)cc3)C2)cc1
Standard InChI: InChI=1S/C21H20N2O/c1-13-3-7-15(8-4-13)17-11-18(16-9-5-14(2)6-10-16)20-19(12-17)22-23-21(20)24/h3-10,12,18H,11H2,1-2H3,(H2,22,23,24)
Standard InChI Key: RRDDWFQJMNWVQI-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
25.1283 -11.6920 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.8921 -11.3968 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.4030 -12.0330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9598 -12.7165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1730 -13.5080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5946 -14.0864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8031 -13.8732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5941 -13.0858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1683 -12.5075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2227 -11.9889 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.2247 -14.4516 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4379 -15.2390 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0722 -15.6083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4374 -14.2384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8595 -15.8173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8590 -14.8168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4938 -16.1867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9603 -13.7170 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5387 -13.1387 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5392 -14.1434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1735 -14.5086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3261 -13.3518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9609 -14.7217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3307 -14.3524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
1 9 2 0
4 9 1 0
3 10 1 0
11 12 1 0
11 14 2 0
12 15 2 0
13 15 1 0
13 16 2 0
14 16 1 0
13 17 1 0
7 11 1 0
18 19 1 0
18 21 2 0
19 22 2 0
20 22 1 0
20 23 2 0
21 23 1 0
20 24 1 0
5 18 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 316.40 | Molecular Weight (Monoisotopic): 316.1576 | AlogP: 4.81 | #Rotatable Bonds: 2 |
Polar Surface Area: 48.91 | Molecular Species: ACID | HBA: 2 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.22 | CX Basic pKa: 2.80 | CX LogP: 5.09 | CX LogD: 3.69 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.71 | Np Likeness Score: -0.01 |
References
1. Shakil NA, Singh MK, Sathiyendiran M, Kumar J, Padaria JC.. (2013) Microwave synthesis, characterization and bio-efficacy evaluation of novel chalcone based 6-carbethoxy-2-cyclohexen-1-one and 2H-indazol-3-ol derivatives., 59 [PMID:23229055] [10.1016/j.ejmech.2012.10.038] |